ADAMTSL3 and diabetes mellitus: In particular, PARD3 has been associated with the signaling pathway related to diabetes [40]; CSMD1 affected BMI and blood lipid levels [41]; ADAMTSL3 was linked to metabolic impairment, especially for incipient diabetes, which was defined on the basis of both fasting and non-fasting blood glucose and the distribution of lean body mass [42,43,44]; TEX2 was associated with diabetes and impaired lipid metabolism [45].